Primary hypercholesterolaemia – Diagnostics – Overview of Information and Clinical Research

Primary hypercholesterolaemia is a condition characterized by elevated levels of “bad” cholesterol in the blood, often without any symptoms until serious complications develop. Understanding when and how to get tested is essential for protecting your heart and blood vessels from long-term damage.

Introduction: Who Should Undergo Diagnostics

Primary hypercholesterolaemia is a condition where your blood contains too much low-density lipoprotein cholesterol, commonly known as LDL or “bad” cholesterol. The challenging aspect of this condition is that it rarely causes any noticeable symptoms in most people. You could have dangerously high cholesterol levels for years without feeling unwell at all. This silent nature makes regular diagnostic screening absolutely vital for catching the problem before it leads to heart attacks or strokes.^[1]

Because high cholesterol typically develops without warning signs, healthcare professionals recommend regular screening for specific groups of people. The American Heart Association suggests that children should have their first cholesterol screening between ages 9 and 11, then again between 17 and 21. After that, many adults should check their cholesterol every five years. However, if you have a family history of early heart disease or childhood heart problems, your doctor may recommend starting screenings much earlier.^[3]

Certain people face higher risks and should seek diagnostic testing more frequently. If you are older than 40, you naturally have a higher chance of developing elevated cholesterol levels. Women who have gone through menopause are also at increased risk. Additionally, people with diabetes, high blood pressure, or a family history of premature heart disease should be especially vigilant about getting tested. If you smoke, live with obesity, or lead a sedentary lifestyle, these factors increase your likelihood of developing high cholesterol.^[1]^[2]

It’s advisable to seek diagnostic testing if you have any combination of risk factors, even if you feel perfectly healthy. For instance, if you are a man aged 45 or older, or a woman aged 55 or older, and you have high blood pressure or diabetes, your healthcare provider will likely recommend cholesterol testing. The same applies if you have close relatives who experienced heart attacks or needed heart procedures before age 55 for men or before age 65 for women. These family patterns can indicate an inherited form of high cholesterol that requires early detection and management.^[2]^[6]

⚠️ Important

In rare cases, people with severe hypercholesterolaemia may notice physical signs such as yellowish patches around the eyes, bumps around the knees or knuckles, a swollen Achilles tendon, or a whitish-gray half-moon shape on the outer edge of the cornea. If you notice any of these signs, you should seek medical evaluation promptly, as they indicate very high cholesterol levels that require immediate attention.^[1]^[6]

Diagnostic Methods for Identifying Hypercholesterolaemia

The cornerstone of diagnosing primary hypercholesterolaemia is a blood test called a lipid panel or lipid profile. This test measures the amounts of different types of fats in your blood, including total cholesterol, LDL cholesterol (the “bad” kind), HDL cholesterol (the “good” kind), and triglycerides. The lipid panel provides your doctor with a complete picture of your cholesterol status and helps determine whether you have hypercholesterolaemia.^[1]^[4]

Before having this blood test, you typically need to fast for a period of time, usually between 9 and 12 hours. This means not eating or drinking anything except water before your blood is drawn. Fasting ensures that the measurements are accurate and not influenced by recent meals. However, in some cases, non-fasting tests may be appropriate. Your healthcare provider will give you specific instructions based on your individual situation.^[1]

When interpreting the results of your lipid panel, your doctor considers multiple factors, not just the numbers alone. What counts as “high” cholesterol depends on your other risk factors for cardiovascular disease. For adults, LDL cholesterol levels of 190 mg/dL or higher are considered high regardless of other risk factors. However, if you have one major risk factor like diabetes or high blood pressure, levels above 160 mg/dL may be concerning. If you have two or more risk factors, your doctor may be worried about levels above 130 mg/dL.^[1]^[2]

For children suspected of having high cholesterol, the diagnostic thresholds are different. LDL cholesterol levels over 160 mg/dL in children are considered elevated and warrant further investigation. In severe cases, whether in children or adults, LDL cholesterol levels can soar above 500 mg/dL, indicating a very serious condition that requires immediate treatment.^[13]

Beyond the basic lipid panel, your healthcare provider will conduct a thorough medical history review. They will ask detailed questions about your family’s health, particularly whether your siblings, parents, aunts, uncles, or grandparents had high cholesterol or heart disease, especially at young ages. This family history is crucial because it can reveal patterns that suggest familial hypercholesterolaemia, an inherited form of the condition that tends to run in families and can cause particularly high cholesterol levels from birth.^[13]

During your physical examination, your doctor will look for physical signs of severe hypercholesterolaemia. They may check your eyelids for yellowish deposits called xanthelasma, examine your hands and elbows for bumps called xanthomas, feel the tendons in your heels and hands for thickening, and look at your eyes for a grayish or white ring around the colored part of your eye. These physical findings, while uncommon, can indicate that cholesterol has been building up in your body for a long time.^[13]^[1]

Another important calculation your doctor performs is determining your non-HDL cholesterol level. This is done by subtracting your HDL cholesterol (the good kind) from your total cholesterol. Non-HDL cholesterol represents all the potentially harmful cholesterol particles in your blood and can sometimes be a better predictor of heart disease risk than LDL cholesterol alone.^[4]

Your doctor may also assess levels of other blood fats. Triglycerides are another type of fat in the blood, and high levels can accompany high LDL cholesterol. Some healthcare providers may also test for apolipoprotein B or lipoprotein(a), which are additional markers that can help assess cardiovascular risk more precisely. Lipoprotein(a) levels at or above the 80th percentile for the general population are considered abnormal and linked to elevated cardiovascular risk.^[4]

Genetic Testing for Familial Hypercholesterolaemia

If your doctor suspects that you have familial hypercholesterolaemia based on your cholesterol levels, family history, and physical signs, they may recommend genetic testing. Familial hypercholesterolaemia is caused by inherited genetic changes that affect how your body regulates and removes cholesterol from the blood. About 60 to 80 percent of people with this inherited form have a specific genetic change that can be identified through testing.^[6]

Genetic testing can confirm the diagnosis of familial hypercholesterolaemia and help you better understand your risk for coronary artery disease and heart attack. If genetic testing reveals that you have familial hypercholesterolaemia, your doctor may suggest that your family members also undergo genetic counseling and testing. This is because familial hypercholesterolaemia runs in families, and identifying affected relatives early allows them to start treatment before complications develop.^[6]^[13]

The genetic test itself typically requires a blood sample, and the results can take several weeks to come back. Your healthcare provider may refer you to a genetic counselor who can explain what the test results mean for you and your family. A confirmed genetic diagnosis can also influence treatment decisions, as people with familial hypercholesterolaemia often require more aggressive cholesterol-lowering treatment than those with other causes of high cholesterol.^[13]

Ruling Out Secondary Causes

Before concluding that you have primary hypercholesterolaemia, your doctor needs to rule out other medical conditions that can cause high cholesterol. These are called secondary causes. Several health problems can elevate cholesterol levels, including an underactive thyroid gland (hypothyroidism), diabetes, kidney disease (particularly nephrotic syndrome), and liver disease that blocks the flow of bile (cholestatic liver disease).^[1]^[4]

Your doctor may order additional blood tests to check your thyroid function, blood sugar levels, kidney function, and liver enzymes. These tests help identify whether an underlying condition is causing your high cholesterol. Additionally, certain medications can raise cholesterol levels, including amiodarone (used for heart rhythm problems), some blood pressure medications like hydrochlorothiazide, cyclosporine (an immune-suppressing drug), and rosiglitazone (a diabetes medication). Your doctor will review all the medications you take to determine if any might be contributing to your elevated cholesterol.^[1]

⚠️ Important

Regular cholesterol screening is essential because high cholesterol increases your risk of heart disease by about twice that of people with ideal levels. In the United States, about 34 million adults have high blood cholesterol, and nearly one-third of American adults have elevated LDL cholesterol. Despite these alarming numbers, many people who could benefit from treatment are not receiving it. Getting diagnosed is the first step toward protecting your heart health.^[7]^[1]

Diagnostics for Clinical Trial Qualification

When researchers conduct clinical trials to test new treatments for hypercholesterolaemia, they need to carefully select participants who meet specific criteria. The diagnostic tests used for clinical trial qualification are often more detailed and standardized than those used in routine clinical practice. These tests ensure that participants truly have the condition being studied and help researchers measure how well the experimental treatment works.^[10]

The foundation of clinical trial qualification is still the lipid panel blood test. However, clinical trials typically have very specific LDL cholesterol level requirements for enrollment. For instance, some trials might only accept participants with LDL cholesterol levels above a certain threshold, such as 130 mg/dL, 160 mg/dL, or 190 mg/dL, depending on the study’s goals. Researchers use these cutoffs to ensure they are studying people whose cholesterol is high enough to potentially benefit from the new treatment being tested.^[2]

Clinical trials often require multiple baseline cholesterol measurements taken on different days before enrollment. This approach helps confirm that the high cholesterol levels are consistent and not just a one-time finding. Some trials may require participants to have been on a stable dose of their current cholesterol medications for a certain period before joining the study. Others might require participants to stop taking cholesterol medications for a time (called a washout period) to see their true, untreated cholesterol levels.^[10]

Beyond cholesterol levels, clinical trials typically assess participants’ overall cardiovascular risk. This assessment may include measuring blood pressure, checking for diabetes through blood sugar tests, evaluating kidney function, and reviewing medical history for previous heart attacks, strokes, or other cardiovascular events. Trials focused on secondary prevention (preventing additional cardiovascular events in people who have already had one) specifically enroll participants with known cardiovascular disease or conditions that carry equivalent risk.^[10]

Some clinical trials, particularly those testing treatments for familial hypercholesterolaemia, require genetic confirmation of the diagnosis. Participants may need to undergo genetic testing and have a documented genetic mutation associated with familial hypercholesterolaemia before they can enroll. This genetic requirement ensures that the study population is homogeneous and that the treatment being tested is evaluated in the specific group most likely to benefit from it.^[6]

Clinical trials may also measure additional biomarkers beyond the standard lipid panel. These might include apolipoprotein B levels, lipoprotein(a) levels, or markers of inflammation like high-sensitivity C-reactive protein. These additional measurements help researchers understand not just whether the treatment lowers cholesterol, but also whether it affects other factors that contribute to cardiovascular disease risk.^[4]

During the clinical trial, participants undergo frequent monitoring with repeated lipid panels to track how their cholesterol levels respond to the treatment. These follow-up tests are more frequent than in routine clinical care, often occurring every few weeks or months. This intensive monitoring allows researchers to precisely measure the treatment’s effects and identify any safety concerns early. The data collected from these standardized diagnostic tests ultimately determine whether a new treatment is effective enough to receive regulatory approval.^[10]

Prognosis and Survival Rate

Prognosis

The outlook for people with primary hypercholesterolaemia depends heavily on several factors, including how early the condition is detected, how high the cholesterol levels are, what other risk factors are present, and how well the condition is managed with treatment. When hypercholesterolaemia is diagnosed early and properly treated, the risk of heart attacks and strokes can be significantly reduced, and people can expect to live normal, healthy lives.^[6]

For people with familial hypercholesterolaemia who receive early diagnosis and treatment, research shows that the risk of developing coronary artery disease can be reduced by about 80 percent. This dramatic improvement demonstrates the critical importance of finding and treating the condition before it causes heart damage. Children diagnosed with familial hypercholesterolaemia may need to start statin therapy as early as age 8 to 10 to prevent cholesterol from building up in their arteries during childhood and adolescence.^[6]

However, when familial hypercholesterolaemia goes untreated, the prognosis is much more concerning. Without treatment, heart attacks occur in approximately 30 percent of women with familial hypercholesterolaemia by age 60, and in about 50 percent of men by age 50. These statistics highlight the serious consequences of undiagnosed or inadequately treated high cholesterol, particularly the inherited form of the condition.^[6]

The prognosis also varies based on whether someone has already experienced cardiovascular complications. People who have already had a heart attack, stroke, or other cardiovascular event face higher risks of additional events compared to those who have never had such complications. This is why aggressive cholesterol management is especially important for secondary prevention in people with established cardiovascular disease.^[10]

Survival rate

Specific survival rate data for primary hypercholesterolaemia alone is not typically reported, because the condition itself does not directly cause death. Instead, hypercholesterolaemia increases the risk of developing atherosclerotic cardiovascular disease, which is the leading cause of death worldwide. People with high cholesterol have approximately twice the risk of developing heart disease compared to those with ideal cholesterol levels.^[7]

What significantly affects survival is whether cardiovascular complications develop and how they are treated. The earlier cholesterol-lowering treatment begins, and the more effectively cholesterol levels are reduced, the better the long-term survival prospects. Research consistently shows that lowering LDL cholesterol reduces the risk of cardiovascular events and death proportional to how much the cholesterol is reduced. The principle is straightforward: the greater the decrease in LDL cholesterol, the greater the reduction in cardiovascular risk and improvement in survival.^[10]

#1 Clinical Trials Search in Europe